Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Malignant Lymphoma

Free Subscription 03.11.2025 4 Blood 2 BMC Cancer 3 Br J Haematol 1 Cancer Res 2 Haematologica 1 J Am Acad Dermatol 4 Leuk Lymphoma 1 Leukemia 1 Oncology (Williston Park)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Blood

1. SHANMUGAM M
   Starving lymphoma with alpha-KG supplementation.
   Blood. 2025;146:2151-2153.
   PubMed        
   
   
2. PANDIRI M, Arber DA
   Rare composite of Rosai-Dorfman-Destombes disease and nodular lymphocyte-predominant B-cell (Hodgkin) lymphoma.
   Blood. 2025;146:2272.
   PubMed        
   
   
3. RONCERAY L, Huibers MHW, Reutter K, Abla O, et al
   High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition.
   Blood. 2025 Oct 29:blood.2025031086. doi: 10.1182/blood.2025031086.
   PubMed         Abstract available
   
   
4. VAN MEERTEN T, Kersten MJ, Iacoboni G, Hess GR, et al
   Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 Cohort 3.
   Blood. 2025 Oct 29:blood.2025029734. doi: 10.1182/blood.2025029734.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. KIM JH, Bea S, Choi Y, Yoon SE, et al
   Effectiveness of axicabtagene ciloleucel versus conventional treatments as first-line therapy for high-risk large B-cell lymphoma: an external comparator study.
   BMC Cancer. 2025;25:1681.
   PubMed         Abstract available
   
   
6. LU S, Xu L, Lan Y, Wang C, et al
   Study of plasma exosomal miRNAs as novel biomarkers for differentiating primary central nervous system lymphoma and glioblastoma.
   BMC Cancer. 2025;25:1657.
   PubMed         Abstract available
   
   

   
   Br J Haematol

7. BRAENDSTRUP P, Mortensen TB, El-Galaly TC, Moller MB, et al
   Outcome of T-cell/histiocyte-rich large B-cell lymphoma-A Danish nationwide matched cohort study.
   Br J Haematol. 2025 Oct 28. doi: 10.1111/bjh.70217.
   PubMed        
   
   
8. GORDON MJ, Lakhotia R, Pittaluga S, Pack SD, et al
   Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma.
   Br J Haematol. 2025 Oct 30. doi: 10.1111/bjh.70234.
   PubMed        
   
   
9. LOSSOS IS, Martin JL, Chapman JR, Pongas GN, et al
   Peripheral blood involvement in extra-nodal marginal zone lymphoma.
   Br J Haematol. 2025 Oct 31. doi: 10.1111/bjh.70232.
   PubMed        
   
   

   
   Cancer Res

10. IANEVSKI A, Nader K, Nguyen J, Sorger H, et al
    Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.
    Cancer Res. 2025 Oct 30. doi: 10.1158/0008-5472.CAN-25-0881.
    PubMed         Abstract available
    
    

    
    Haematologica

11. JIANG L, Ladetto M, Hermine O, Kluin-Nelemans JC, et al
    Marked survival gains in patients
    Haematologica. 2025 Oct 30. doi: 10.3324/haematol.2025.288929.
    PubMed         Abstract available
    
    
12. HESS B, Moskowitz A, Davis JA, Strati P, et al
    Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R.
    Haematologica. 2025 Oct 30. doi: 10.3324/haematol.2025.288232.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

13. FISHER C, Wohltmann WE
    JAAD Game Changers: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".
    J Am Acad Dermatol. 2025 Oct 29:S0190-9622(25)03101.
    PubMed        
    
    

    
    Leuk Lymphoma

14. REESE M, Hatfield J, Zamora C, Dittus C, et al
    Nivolumab with doxorubicin, vinblastine, and dacarbazine for the frontline treatment of central nervous system classical Hodgkin lymphoma.
    Leuk Lymphoma. 2025 Oct 31:1-4. doi: 10.1080/10428194.2025.2577256.
    PubMed        
    
    
15. LOPEDOTE P, Shouse G, Chen L, Smith DL, et al
    Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
    Leuk Lymphoma. 2025 Oct 31:1-4. doi: 10.1080/10428194.2025.2566316.
    PubMed        
    
    
16. PICHARDO-RODRIGUEZ R, Vela-Ruiz JM, Villela L, Torres Viera MA, et al
    Prognostic relevance of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis and dose-response evidence.
    Leuk Lymphoma. 2025 Oct 27:1-13. doi: 10.1080/10428194.2025.2566980.
    PubMed         Abstract available
    
    
17. DING W, Li A, Sun M, Xiong Y, et al
    CD19 CAR-T induces complete and durable remission in cold agglutinin syndrome associated relapse and refractory diffuse large B cell lymphoma.
    Leuk Lymphoma. 2025 Oct 26:1-3. doi: 10.1080/10428194.2025.2573873.
    PubMed        
    
    

    
    Leukemia

18. KHOUJA M, Kehden B, Blair D, Kuffer C, et al
    ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study.
    Leukemia. 2025 Oct 27. doi: 10.1038/s41375-025-02759.
    PubMed         Abstract available
    
    

    
    Oncology (Williston Park)

19. WAEL ABDULLA MOH KHAIR MD
    Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era.
    Oncology (Williston Park). 2025;39:424-430.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.